Air Products and Chemicals, Inc. (BMV:APD)
Mexico · Delayed Price · Currency is MXN 5,266.58
-95.57 (-1.78%)
At close: Jun 17, 2025
Theseus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2016 - 2020 |
Net Income | 1,551 | 3,828 | 2,300 | 2,256 | 2,099 | 1,887 | Upgrade |
Depreciation & Amortization | 1,532 | 1,451 | 1,358 | 1,338 | 1,321 | 1,185 | Upgrade |
Loss (Gain) From Sale of Assets | -1,698 | -1,607 | -15.8 | -24.1 | -37.2 | -45.8 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | 23.2 | - | Upgrade |
Loss (Gain) on Equity Investments | -219.7 | -206 | -261.2 | -214.7 | -138.2 | -161.9 | Upgrade |
Stock-Based Compensation | 81.3 | 61.8 | 59.9 | 48.4 | 44.5 | 53.5 | Upgrade |
Other Operating Activities | 2,759 | 335.8 | 227.5 | -107.1 | 21.6 | 431.7 | Upgrade |
Change in Accounts Receivable | -192 | -111 | 130.7 | -475.2 | -130.5 | 43.2 | Upgrade |
Change in Inventory | -62.4 | -137.8 | -129.4 | -94.3 | -47.2 | -5.2 | Upgrade |
Change in Accounts Payable | -378.7 | -338.7 | -213.3 | 532.5 | 187.9 | -31.9 | Upgrade |
Change in Other Net Operating Assets | -383.4 | 404.5 | -212.8 | -78.8 | 6.5 | -46.2 | Upgrade |
Operating Cash Flow | 2,953 | 3,647 | 3,206 | 3,230 | 3,342 | 3,265 | Upgrade |
Operating Cash Flow Growth | -20.04% | 13.73% | -0.74% | -3.34% | 2.37% | 9.93% | Upgrade |
Capital Expenditures | -7,580 | -6,797 | -4,626 | -2,927 | -2,464 | -2,509 | Upgrade |
Sale of Property, Plant & Equipment | 2,038 | 1,879 | 25.4 | 46.2 | 37.5 | 80.3 | Upgrade |
Cash Acquisitions | -59.9 | - | - | -65.1 | -10.5 | -183.3 | Upgrade |
Investment in Securities | -302.9 | 329.3 | -655.1 | -918.8 | -301.5 | -951.9 | Upgrade |
Other Investing Activities | 139.2 | 72.4 | 4.8 | 7 | 5.8 | 3.9 | Upgrade |
Investing Cash Flow | -5,826 | -4,919 | -5,916 | -3,857 | -2,733 | -3,560 | Upgrade |
Short-Term Debt Issued | - | - | 268.2 | 17.9 | 1 | - | Upgrade |
Long-Term Debt Issued | - | 4,678 | 3,516 | 766.2 | 178.9 | 4,896 | Upgrade |
Total Debt Issued | 4,751 | 4,678 | 3,784 | 784.1 | 179.9 | 4,896 | Upgrade |
Short-Term Debt Repaid | - | -289.9 | - | - | - | -54.9 | Upgrade |
Long-Term Debt Repaid | - | -486.2 | -615.4 | -400 | -462.9 | -406.6 | Upgrade |
Total Debt Repaid | -896.2 | -776.1 | -615.4 | -400 | -462.9 | -461.5 | Upgrade |
Net Debt Issued (Repaid) | 3,855 | 3,902 | 3,169 | 384.1 | -283 | 4,434 | Upgrade |
Issuance of Common Stock | 2.8 | 7.9 | 24 | 19.3 | 10.6 | 34.1 | Upgrade |
Common Dividends Paid | -1,579 | -1,565 | -1,497 | -1,383 | -1,257 | -1,104 | Upgrade |
Other Financing Activities | 523.3 | 270.2 | -86.8 | -20.7 | 108.2 | -80.1 | Upgrade |
Financing Cash Flow | 2,802 | 2,615 | 1,610 | -1,001 | -1,421 | 3,285 | Upgrade |
Foreign Exchange Rate Adjustments | 20.4 | 19.8 | 6.5 | -130.3 | 27.8 | 14.9 | Upgrade |
Net Cash Flow | -51.4 | 1,363 | -1,094 | -1,758 | -784.1 | 3,004 | Upgrade |
Free Cash Flow | -4,628 | -3,150 | -1,420 | 303.7 | 877.7 | 755.7 | Upgrade |
Free Cash Flow Growth | - | - | - | -65.40% | 16.14% | -22.90% | Upgrade |
Free Cash Flow Margin | -38.38% | -26.03% | -11.27% | 2.39% | 8.50% | 8.53% | Upgrade |
Free Cash Flow Per Share | -20.78 | -14.14 | -6.38 | 1.36 | 3.94 | 3.40 | Upgrade |
Cash Interest Paid | 198.2 | 198.2 | 131.5 | 128.5 | 150.4 | 67.2 | Upgrade |
Cash Income Tax Paid | 969.8 | 615.9 | 645.2 | 369.2 | 383.8 | 379.9 | Upgrade |
Levered Free Cash Flow | -4,706 | -3,337 | -1,841 | 123.41 | 396.03 | 82.13 | Upgrade |
Unlevered Free Cash Flow | -4,583 | -3,188 | -1,730 | 203.41 | 484.65 | 150.44 | Upgrade |
Change in Net Working Capital | 389.4 | -315.6 | 180.1 | -203.4 | -113.3 | -13.2 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.